Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey

Maryia Zhdanava,1 H Lynn Starr,2 Todor I Totev,3 Patrick Lefebvre,1 Aditi Shah,1 Kristy Sheng,4 Dominic Pilon1 1Analysis Group, Inc., Montréal, QC, Canada; 2Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 3Analysis Group, Inc., Boston, MA, USA; 4Analysis Group, Inc., Menlo Park, CA, USACorresp...

Full description

Bibliographic Details
Main Authors: Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
adherence
antipsychotics
covid-19
physician survey
prescribing habits
schizophrenia
Online Access:https://www.dovepress.com/impact-of-covid-19-pandemic-on-prescribing-of-long-acting-injectable-a-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/impact-of-covid-19-pandemic-on-prescribing-of-long-acting-injectable-a-peer-reviewed-fulltext-article-NDT

Similar Items